Adlai Nortye (ANL) Long-Term Investments (2022 - 2025)
Adlai Nortye's (ANL) quarterly Long-Term Investments came in at $4.2 million in Q4 2025, up 60600.0% year-on-year from N/an in Q4 2024, and up 1.82% on a QoQ basis from $4.2 million in Q2 2025.
Adlai Nortye (ANL) Long-Term Investments (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Long-Term Investments data on file, last reported at $4.2 million in Q4 2025.
- On a quarterly basis, Long-Term Investments rose 60600.0% year-over-year to $4.2 million in Q4 2025; TTM through Dec 2025 was $4.2 million, a 60600.0% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 60600.0% from the prior year.
- Long-Term Investments for Q4 2025 stood at $4.2 million, up from $4.2 million in the prior quarter.
- Over the last five years, Long-Term Investments for ANL reached as high as $21.3 million in Q4 2022 and fell as low as $7000.0 in Q4 2023.
- Historically, Long-Term Investments has averaged $5.7 million across 4 years, with a median of $4.2 million in 2024.
- Across the five-year window, Long-Term Investments slumped 99.97% in 2023 and jumped 60600.0% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $21.3 million in 2022, then slumped by 99.97% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024, then soared by 60600.0% to $4.2 million in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $4.2 million in Q4 2025, $4.2 million in Q2 2025, and $7000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.25 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Dec 31, 2024 | 7,000.00 |
| Jun 30, 2024 | 4.20 Mn |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 21.29 Mn |